비교리스트

 카트 문의
시장보고서
상품코드
1301436

저침습 수술 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

Minimally Invasive Surgery Market (Procedure: Laparoscopic Surgery, Robotic Surgery, Endoscopic Mucosal Resection, Endoscopic Submucosal Dissection, and Transcatheter) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
발행일: | 리서치사: Transparency Market Research | 페이지 정보: 영문 481 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

저침습 수술 시장 - 보고서의 범위

TMR의 세계 저침습 수술 시장에 대한 보고서는 과거와 현재의 성장 동향과 2023년부터 2031년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻을 수 있는 기회를 조사했습니다. 이 보고서는 세계 저침습 수술의 수익을 제공합니다. 2023년을 기준 연도, 2031년을 예측 연도로 간주하여 2017년부터 2031년까지 시장을 분석합니다. 이 보고서는 또한 2023-2031년간 세계 저침습 수술 시장의 연평균 성장률(CAGR%)을 제공합니다.

란다. 랍니다. 이 보고서는 광범위한 조사를 통해 작성되었으며, 1차 조사에서는 분석가들이 KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체를 인터뷰하여 주요 조사 활동의 대부분을 수행했으며, 2차 조사에서는 주요 기업의 제품 문헌, 연례 보고서, 보도 자료 및 관련 문서에 대한 참조를 통해 저침습 수술 시장을 파악했습니다.

이 보고서는 세계 저침습 수술 시장 경쟁 구도를 자세히 분석합니다. 세계 저침습 수술 시장에서 활동하는 주요 기업이 식별되며, 이들은 다양한 속성 측면에서 프로파일링됩니다. 기업 프로파일, 재무 상태, 최근 동향 및 SWOT는 이 보고서에 소개된 세계 저침습 수술 시장 기업의 속성입니다.

목차

제1장 서문

제2장 가정과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

  • 개요
  • 시장 역학 : 지역별

제5장 주요 인사이트

  • 지역별 : MIS 수술 상환 시나리오 개요
    • 상환 동향
  • MIS 제품 가격 개요
  • 수술 전체와 비교한 MIS 도입 비율에 관한 데이터
  • MIS와 개복 수술 비교(건수 : 지역별)
  • MIS 연수에 관한 정보
    • MIS 트레이닝 갭
    • 트레이닝에 대해
  • 각 진료과 외과의 수와 현재 MIS를 사용하고 있는 외과의 수(best effort 기반)
  • MIS로 실시할 수 있는 진료과목별 수술 리스트
  • 다양한 국가의 수술 비용
  • 주요 병원 : 지역/국가별
  • COVID-19의 영향 분석

제6장 세계 시장 분석과 예측 : 절차별

  • 서론과 정의
  • 주요 발견과 개발
  • 세계 시장 매출과 수량 예측 : 절차별, 2017-2031
    • 복강경 수술
      • 정형외과
      • 흉부외과
      • 비뇨기과외과
      • 부인과 외과
      • 혈관 수술
      • 일반외과
      • 암 수술
      • 유선 외과
      • 이비인후과 수술
      • 비만 수술
    • 로봇 수술
      • 정형외과
      • 심장 수술
      • 흉부외과
      • 비뇨기과외과
      • 부인과 외과
      • 혈관 수술
      • 일반 외과
      • 암 수술
      • 유선 외과
      • 이비인후과 수술
      • 비만 수술
      • 미용성형 및 성형외과
      • 뇌신경외과
    • 내시경적 점막 절제술
    • 내시경적 점막 하층 박리술
    • 경카테터
      • 심장 수술
      • 혈관 수술
      • 암 수술
      • 비만 수술
  • 세계 시장의 매력 : 수술별

제7장 세계 시장 분석과 예측 : 질환 적응별

  • 서론과 정의
  • 주요 발견과 개발
  • 세계 시장 매출과 수량 예측 : 질환 적응별, 2017-2031
    • 정형외과
      • 무릎
      • 척추
      • 어깨
      • 기타
    • 심장 수술
      • 승모판
      • 대동맥판
      • 구조적 심장병
      • 삼첨판
      • 기타
    • 일반 외과
      • 소화기 외과
      • 간담췌외과
    • 비뇨기과외과
    • 흉부외과
    • 부인과외과
    • 혈관 수술
    • 암 수술
    • 유선 외과
    • 이비인후과 수술
    • 비만 수술
    • 미용성형 및 성형 외과
    • 뇌신경외과
  • 세계 시장의 매력 : 질환별

제8장 세계 시장 분석과 예측 : 최종사용자별

  • 서론과 정의
  • 주요 발견과 개발
  • 세계 시장 매출 예측 : 최종사용자별, 2017-2031
    • 병원
      • 정형외과
      • 심장 수술
      • 흉부외과
      • 비뇨기과외과
      • 부인과 외과
      • 혈관 수술
      • 일반 외과
      • 암 수술
      • 유선 외과
      • 이비인후과 수술
      • 비만 수술
      • 미용성형 및 성형 외과
      • 뇌신경외과
    • 클리닉
      • 정형외과
      • 심장 수술
      • 흉부외과
      • 비뇨기과외과
      • 부인과 외과
      • 혈관 수술
      • 일반 외과
      • 암 수술
      • 유선 외과
      • 이비인후과 수술
      • 비만 수술
      • 미용성형 및 성형 외과
      • 뇌신경외과
    • 외래수술센터(ASC)
      • 정형외과
      • 심장 수술
      • 흉부외과
      • 비뇨기과외과
      • 부인과 외과
      • 혈관 수술
      • 일반 외과
      • 암 수술
      • 유선 외과
      • 이비인후과 수술
      • 비만 수술
      • 미용성형 및 성형 외과
      • 뇌신경외과
    • 기타
      • 정형외과
      • 심장 수술
      • 흉부외과
      • 비뇨기과외과
      • 부인과 외과
      • 혈관 수술
      • 일반 외과
      • 암 수술
      • 유선 외과
      • 이비인후과 수술
      • 비만 수술
      • 미용성형 및 성형 외과
      • 뇌신경외과
  • 세계 시장의 매력 : 최종사용자별

제9장 세계 시장 분석과 예측 : 지역별

  • 주요 조사 결과
  • 세계 시장 매출 예측 : 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 세계 시장의 매력 : 지역별

제10장 북미 시장 분석과 예측

제11장 유럽 시장 분석과 예측

제12장 아시아태평양 시장 분석과 예측

제13장 라틴아메리카 시장 분석과 예측

제14장 중동 및 아프리카 시장 분석과 예측

제15장 경쟁 구도

  • 시장 기업 - 경쟁 매트릭스(기업 Tier 및 규모별)
  • 기업 개요(병원)
    • Apollo Hospitals Enterprise Limited
    • Huntington Hospital
    • Johns Hopkins Hospital
    • Massachusetts General Hospital
    • Rutland Medical Center
    • Saint Michael's Hospital
    • Singapore General Hospital
    • The Ottawa Hospital
    • University of Pittsburgh Medical Center
    • Washington Hospital Healthcare System
  • 기업 개요(기기 공급업체)
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Becton, Dickinson and Company
    • Boston Scientific Corporation
    • CONMED Corporation
    • Johnson &Johnson Services, Inc.
    • Medtronic plc
    • Smith &Nephew plc
    • Stryker Corporation
    • Zimmer Biomet
LSH 23.07.13

Minimally Invasive Surgery Market - Scope of Report

TMR's report on the global Minimally Invasive Surgery market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Minimally Invasive Surgery market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Minimally Invasive Surgery market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Minimally Invasive Surgery market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Minimally Invasive Surgery market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Minimally Invasive Surgery market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Minimally Invasive Surgery market.

The report delves into the competitive landscape of the global Minimally Invasive Surgery market. Key players operating in the global Minimally Invasive Surgery market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Minimally Invasive Surgery market profiled in this report.

Key Questions Answered in Global Minimally Invasive Surgery Market Report:

  • What is the sales/revenue generated by Minimally Invasive Surgery across all regions during the forecast period?
  • What are the opportunities in the global Minimally Invasive Surgery market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Minimally Invasive Surgery Market - Research Objectives and Research Approach

The comprehensive report on the global Minimally Invasive Surgery market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Minimally Invasive Surgery market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Minimally Invasive Surgery market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Minimally Invasive Surgery Market

4. Market Overview

  • 4.1. Overview
  • 4.2. Market Dynamics, by Region
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities

5. Key Insights

  • 5.1. Overview of reimbursement scenario for MIS surgeries by Region
    • 5.1.1. Reimbursement Trends
  • 5.2. Overview of pricing of MIS products
  • 5.3. Data related to percentage of MIS adoption as compared to total procedures
  • 5.4. Comparison between MIS and Open Surgery (Volume, by Region)
  • 5.5. Information related MIS Training
    • 5.5.1. MIS Training Gap
    • 5.5.2. Verbatim about Training
  • 5.6. Number of surgeons in each medical specialty and how many of them use MIS today (as per best-efforts basis)
  • 5.7. List of procedures that can be done by MIS for each specialty
  • 5.8. Cost of Surgery in Different Countries
  • 5.9. Major Hospitals, by Region/Country
  • 5.10. COVID-19 Impact Analysis

6. Global Minimally Invasive Surgery Market Analysis and Forecast, by Procedure

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017-2031
    • 6.3.1. Laparoscopic Surgery
      • 6.3.1.1. Orthopedic Surgery
      • 6.3.1.2. Thoracic Surgery
      • 6.3.1.3. Urology Surgery
      • 6.3.1.4. Gynecology Surgery
      • 6.3.1.5. Vascular Surgery
      • 6.3.1.6. General Surgery
      • 6.3.1.7. Cancer Surgery
      • 6.3.1.8. Breast Surgery
      • 6.3.1.9. Ear, Nose, and Throat Surgery
      • 6.3.1.10. Bariatric Surgery
    • 6.3.2. Robotic Surgery
      • 6.3.2.1. Orthopedic Surgery
      • 6.3.2.2. Cardiac Surgery
      • 6.3.2.3. Thoracic Surgery
      • 6.3.2.4. Urology Surgery
      • 6.3.2.5. Gynecology Surgery
      • 6.3.2.6. Vascular Surgery
      • 6.3.2.7. General Surgery
      • 6.3.2.8. Cancer Surgery
      • 6.3.2.9. Breast Surgery
      • 6.3.2.10. Ear, Nose, and Throat Surgery
      • 6.3.2.11. Bariatric Surgery
      • 6.3.2.12. Cosmetic/Plastic Surgery
      • 6.3.2.13. Neurosurgery
    • 6.3.3. Endoscopic Mucosal Resection
    • 6.3.4. Endoscopic Submucosal Dissection
    • 6.3.5. Transcatheter
      • 6.3.5.1. Cardiac Surgery
      • 6.3.5.2. Vascular Surgery
      • 6.3.5.3. Cancer Surgery
      • 6.3.5.4. Bariatric Surgery
  • 6.4. Global Minimally Invasive Surgery Market Attractiveness, by Procedure

7. Global Minimally Invasive Surgery Market Analysis and Forecast, by Disease Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017-2031
    • 7.3.1. Orthopedic Surgery
      • 7.3.1.1. Knee
      • 7.3.1.2. Spine
      • 7.3.1.3. Shoulder
      • 7.3.1.4. Others
    • 7.3.2. Cardiac Surgery
      • 7.3.2.1. Mitral Valve
      • 7.3.2.2. Aortic Valve
      • 7.3.2.3. Structural Heart Disease
      • 7.3.2.4. Tricuspid Valve
      • 7.3.2.5. Others
    • 7.3.3. General Surgery
      • 7.3.3.1. Gastrointestinal Surgery
      • 7.3.3.2. Hepatobiliary Pancreatic Surgery
    • 7.3.4. Urology Surgery
    • 7.3.5. Thoracic Surgery
    • 7.3.6. Gynecology Surgery
    • 7.3.7. Vascular Surgery
    • 7.3.8. Cancer Surgery
    • 7.3.9. Breast Surgery
    • 7.3.10. Ear, Nose, and Throat Surgery
    • 7.3.11. Bariatric Surgery
    • 7.3.12. Cosmetic/Plastic Surgery
    • 7.3.13. Neurosurgery
  • 7.4. Global Minimally Invasive Surgery Market Attractiveness, by Disease Indication

8. Global Minimally Invasive Surgery Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Global Minimally Invasive Surgery Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
      • 8.3.1.1. Orthopedic Surgery
      • 8.3.1.2. Cardiac Surgery
      • 8.3.1.3. Thoracic Surgery
      • 8.3.1.4. Urology Surgery
      • 8.3.1.5. Gynecology Surgery
      • 8.3.1.6. Vascular Surgery
      • 8.3.1.7. General Surgery
      • 8.3.1.8. Cancer Surgery
      • 8.3.1.9. Breast Surgery
      • 8.3.1.10. Ear, Nose, and Throat Surgery
      • 8.3.1.11. Bariatric Surgery
      • 8.3.1.12. Cosmetic/Plastic Surgery
      • 8.3.1.13. Neurosurgery
    • 8.3.2. Clinics
      • 8.3.2.1. Orthopedic Surgery
      • 8.3.2.2. Cardiac Surgery
      • 8.3.2.3. Thoracic Surgery
      • 8.3.2.4. Urology Surgery
      • 8.3.2.5. Gynecology Surgery
      • 8.3.2.6. Vascular Surgery
      • 8.3.2.7. General Surgery
      • 8.3.2.8. Cancer Surgery
      • 8.3.2.9. Breast Surgery
      • 8.3.2.10. Ear, Nose, and Throat Surgery
      • 8.3.2.11. Bariatric Surgery
      • 8.3.2.12. Cosmetic/Plastic Surgery
      • 8.3.2.13. Neurosurgery
    • 8.3.3. Ambulatory Surgical Centers
      • 8.3.3.1. Orthopedic Surgery
      • 8.3.3.2. Cardiac Surgery
      • 8.3.3.3. Thoracic Surgery
      • 8.3.3.4. Urology Surgery
      • 8.3.3.5. Gynecology Surgery
      • 8.3.3.6. Vascular Surgery
      • 8.3.3.7. General Surgery
      • 8.3.3.8. Cancer Surgery
      • 8.3.3.9. Breast Surgery
      • 8.3.3.10. Ear, Nose, and Throat Surgery
      • 8.3.3.11. Bariatric Surgery
      • 8.3.3.12. Cosmetic/Plastic Surgery
      • 8.3.3.13. Neurosurgery
    • 8.3.4. Others
      • 8.3.4.1. Orthopedic Surgery
      • 8.3.4.2. Cardiac Surgery
      • 8.3.4.3. Thoracic Surgery
      • 8.3.4.4. Urology Surgery
      • 8.3.4.5. Gynecology Surgery
      • 8.3.4.6. Vascular Surgery
      • 8.3.4.7. General Surgery
      • 8.3.4.8. Cancer Surgery
      • 8.3.4.9. Breast Surgery
      • 8.3.4.10. Ear, Nose, and Throat Surgery
      • 8.3.4.11. Bariatric Surgery
      • 8.3.4.12. Cosmetic/Plastic Surgery
      • 8.3.4.13. Neurosurgery
  • 8.4. Global Minimally Invasive Surgery Market Attractiveness, by End-user

9. Global Minimally Invasive Surgery Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Global Minimally Invasive Surgery Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Global Minimally Invasive Surgery Market Attractiveness, by Region

10. North America Minimally Invasive Surgery Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. North America Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017-2031
    • 10.2.1. Laparoscopic Surgery
      • 10.2.1.1. Orthopedic Surgery
      • 10.2.1.2. Thoracic Surgery
      • 10.2.1.3. Urology Surgery
      • 10.2.1.4. Gynecology Surgery
      • 10.2.1.5. Vascular Surgery
      • 10.2.1.6. General Surgery
      • 10.2.1.7. Cancer Surgery
      • 10.2.1.8. Breast Surgery
      • 10.2.1.9. Ear, Nose, and Throat Surgery
      • 10.2.1.10. Bariatric Surgery
    • 10.2.2. Robotic Surgery
      • 10.2.2.1. Orthopedic Surgery
      • 10.2.2.2. Cardiac Surgery
      • 10.2.2.3. Thoracic Surgery
      • 10.2.2.4. Urology Surgery
      • 10.2.2.5. Gynecology Surgery
      • 10.2.2.6. Vascular Surgery
      • 10.2.2.7. General Surgery
      • 10.2.2.8. Cancer Surgery
      • 10.2.2.9. Breast Surgery
      • 10.2.2.10. Ear, Nose, and Throat Surgery
      • 10.2.2.11. Bariatric Surgery
      • 10.2.2.12. Cosmetic/Plastic Surgery
      • 10.2.2.13. Neurosurgery
    • 10.2.3. Endoscopic Mucosal Resection
    • 10.2.4. Endoscopic Submucosal Dissection
    • 10.2.5. Transcatheter
      • 10.2.5.1. Cardiac Surgery
      • 10.2.5.2. Vascular Surgery
      • 10.2.5.3. Cancer Surgery
      • 10.2.5.4. Bariatric Surgery
  • 10.3. North America Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017-2031
    • 10.3.1. Orthopedic Surgery
      • 10.3.1.1. Knee
      • 10.3.1.2. Spine
      • 10.3.1.3. Shoulder
      • 10.3.1.4. Others
    • 10.3.2. Cardiac Surgery
      • 10.3.2.1. Mitral Valve
      • 10.3.2.2. Aortic Valve
      • 10.3.2.3. Structural Heart Disease
      • 10.3.2.4. Tricuspid Valve
      • 10.3.2.5. Others
    • 10.3.3. General Surgery
      • 10.3.3.1. Gastrointestinal Surgery
      • 10.3.3.2. Hepatobiliary Pancreatic Surgery
    • 10.3.4. Urology Surgery
    • 10.3.5. Thoracic Surgery
    • 10.3.6. Gynecology Surgery
    • 10.3.7. Vascular Surgery
    • 10.3.8. Cancer Surgery
    • 10.3.9. Breast Surgery
    • 10.3.10. Ear, Nose, and Throat Surgery
    • 10.3.11. Bariatric Surgery
    • 10.3.12. Cosmetic/Plastic Surgery
    • 10.3.13. Neurosurgery
  • 10.4. North America Minimally Invasive Surgery Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
      • 10.4.1.1. Orthopedic Surgery
      • 10.4.1.2. Cardiac Surgery
      • 10.4.1.3. Thoracic Surgery
      • 10.4.1.4. Urology Surgery
      • 10.4.1.5. Gynecology Surgery
      • 10.4.1.6. Vascular Surgery
      • 10.4.1.7. General Surgery
      • 10.4.1.8. Cancer Surgery
      • 10.4.1.9. Breast Surgery
      • 10.4.1.10. Ear, Nose, and Throat Surgery
      • 10.4.1.11. Bariatric Surgery
      • 10.4.1.12. Cosmetic/Plastic Surgery
      • 10.4.1.13. Neurosurgery
    • 10.4.2. Clinics
      • 10.4.2.1. Orthopedic Surgery
      • 10.4.2.2. Cardiac Surgery
      • 10.4.2.3. Thoracic Surgery
      • 10.4.2.4. Urology Surgery
      • 10.4.2.5. Gynecology Surgery
      • 10.4.2.6. Vascular Surgery
      • 10.4.2.7. General Surgery
      • 10.4.2.8. Cancer Surgery
      • 10.4.2.9. Breast Surgery
      • 10.4.2.10. Ear, Nose, and Throat Surgery
      • 10.4.2.11. Bariatric Surgery
      • 10.4.2.12. Cosmetic/Plastic Surgery
      • 10.4.2.13. Neurosurgery
    • 10.4.3. Ambulatory Surgical Centers
      • 10.4.3.1. Orthopedic Surgery
      • 10.4.3.2. Cardiac Surgery
      • 10.4.3.3. Thoracic Surgery
      • 10.4.3.4. Urology Surgery
      • 10.4.3.5. Gynecology Surgery
      • 10.4.3.6. Vascular Surgery
      • 10.4.3.7. General Surgery
      • 10.4.3.8. Cancer Surgery
      • 10.4.3.9. Breast Surgery
      • 10.4.3.10. Ear, Nose, and Throat Surgery
      • 10.4.3.11. Bariatric Surgery
      • 10.4.3.12. Cosmetic/Plastic Surgery
      • 10.4.3.13. Neurosurgery
    • 10.4.4. Others
      • 10.4.4.1. Orthopedic Surgery
      • 10.4.4.2. Cardiac Surgery
      • 10.4.4.3. Thoracic Surgery
      • 10.4.4.4. Urology Surgery
      • 10.4.4.5. Gynecology Surgery
      • 10.4.4.6. Vascular Surgery
      • 10.4.4.7. General Surgery
      • 10.4.4.8. Cancer Surgery
      • 10.4.4.9. Breast Surgery
      • 10.4.4.10. Ear, Nose, and Throat Surgery
      • 10.4.4.11. Bariatric Surgery
      • 10.4.4.12. Cosmetic/Plastic Surgery
      • 10.4.4.13. Neurosurgery
  • 10.5. North America Minimally Invasive Surgery Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. North America Minimally Invasive Surgery Market Attractiveness Analysis
    • 10.6.1. By Procedure
    • 10.6.2. By Disease Indication
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Minimally Invasive Surgery Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Europe Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017-2031
    • 11.2.1. Laparoscopic Surgery
      • 11.2.1.1. Orthopedic Surgery
      • 11.2.1.2. Thoracic Surgery
      • 11.2.1.3. Urology Surgery
      • 11.2.1.4. Gynecology Surgery
      • 11.2.1.5. Vascular Surgery
      • 11.2.1.6. General Surgery
      • 11.2.1.7. Cancer Surgery
      • 11.2.1.8. Breast Surgery
      • 11.2.1.9. Ear, Nose, and Throat Surgery
      • 11.2.1.10. Bariatric Surgery
    • 11.2.2. Robotic Surgery
      • 11.2.2.1. Orthopedic Surgery
      • 11.2.2.2. Cardiac Surgery
      • 11.2.2.3. Thoracic Surgery
      • 11.2.2.4. Urology Surgery
      • 11.2.2.5. Gynecology Surgery
      • 11.2.2.6. Vascular Surgery
      • 11.2.2.7. General Surgery
      • 11.2.2.8. Cancer Surgery
      • 11.2.2.9. Breast Surgery
      • 11.2.2.10. Ear, Nose, and Throat Surgery
      • 11.2.2.11. Bariatric Surgery
      • 11.2.2.12. Cosmetic/Plastic Surgery
      • 11.2.2.13. Neurosurgery
    • 11.2.3. Endoscopic Mucosal Resection
    • 11.2.4. Endoscopic Submucosal Dissection
    • 11.2.5. Transcatheter
      • 11.2.5.1. Cardiac Surgery
      • 11.2.5.2. Vascular Surgery
      • 11.2.5.3. Cancer Surgery
      • 11.2.5.4. Bariatric Surgery
  • 11.3. Europe Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017-2031
    • 11.3.1. Orthopedic Surgery
      • 11.3.1.1. Knee
      • 11.3.1.2. Spine
      • 11.3.1.3. Shoulder
      • 11.3.1.4. Others
    • 11.3.2. Cardiac Surgery
      • 11.3.2.1. Mitral Valve
      • 11.3.2.2. Aortic Valve
      • 11.3.2.3. Structural Heart Disease
      • 11.3.2.4. Tricuspid Valve
      • 11.3.2.5. Others
    • 11.3.3. General Surgery
      • 11.3.3.1. Gastrointestinal Surgery
      • 11.3.3.2. Hepatobiliary Pancreatic Surgery
    • 11.3.4. Urology Surgery
    • 11.3.5. Thoracic Surgery
    • 11.3.6. Gynecology Surgery
    • 11.3.7. Vascular Surgery
    • 11.3.8. Cancer Surgery
    • 11.3.9. Breast Surgery
    • 11.3.10. Ear, Nose, and Throat Surgery
    • 11.3.11. Bariatric Surgery
    • 11.3.12. Cosmetic/Plastic Surgery
    • 11.3.13. Neurosurgery
  • 11.4. Europe Minimally Invasive Surgery Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
      • 11.4.1.1. Orthopedic Surgery
      • 11.4.1.2. Cardiac Surgery
      • 11.4.1.3. Thoracic Surgery
      • 11.4.1.4. Urology Surgery
      • 11.4.1.5. Gynecology Surgery
      • 11.4.1.6. Vascular Surgery
      • 11.4.1.7. General Surgery
      • 11.4.1.8. Cancer Surgery
      • 11.4.1.9. Breast Surgery
      • 11.4.1.10. Ear, Nose, and Throat Surgery
      • 11.4.1.11. Bariatric Surgery
      • 11.4.1.12. Cosmetic/Plastic Surgery
      • 11.4.1.13. Neurosurgery
    • 11.4.2. Clinics
      • 11.4.2.1. Orthopedic Surgery
      • 11.4.2.2. Cardiac Surgery
      • 11.4.2.3. Thoracic Surgery
      • 11.4.2.4. Urology Surgery
      • 11.4.2.5. Gynecology Surgery
      • 11.4.2.6. Vascular Surgery
      • 11.4.2.7. General Surgery
      • 11.4.2.8. Cancer Surgery
      • 11.4.2.9. Breast Surgery
      • 11.4.2.10. Ear, Nose, and Throat Surgery
      • 11.4.2.11. Bariatric Surgery
      • 11.4.2.12. Cosmetic/Plastic Surgery
      • 11.4.2.13. Neurosurgery
    • 11.4.3. Ambulatory Surgical Centers
      • 11.4.3.1. Orthopedic Surgery
      • 11.4.3.2. Cardiac Surgery
      • 11.4.3.3. Thoracic Surgery
      • 11.4.3.4. Urology Surgery
      • 11.4.3.5. Gynecology Surgery
      • 11.4.3.6. Vascular Surgery
      • 11.4.3.7. General Surgery
      • 11.4.3.8. Cancer Surgery
      • 11.4.3.9. Breast Surgery
      • 11.4.3.10. Ear, Nose, and Throat Surgery
      • 11.4.3.11. Bariatric Surgery
      • 11.4.3.12. Cosmetic/Plastic Surgery
      • 11.4.3.13. Neurosurgery
    • 11.4.4. Others
      • 11.4.4.1. Orthopedic Surgery
      • 11.4.4.2. Cardiac Surgery
      • 11.4.4.3. Thoracic Surgery
      • 11.4.4.4. Urology Surgery
      • 11.4.4.5. Gynecology Surgery
      • 11.4.4.6. Vascular Surgery
      • 11.4.4.7. General Surgery
      • 11.4.4.8. Cancer Surgery
      • 11.4.4.9. Breast Surgery
      • 11.4.4.10. Ear, Nose, and Throat Surgery
      • 11.4.4.11. Bariatric Surgery
      • 11.4.4.12. Cosmetic/Plastic Surgery
      • 11.4.4.13. Neurosurgery
  • 11.5. Europe Minimally Invasive Surgery Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Europe Minimally Invasive Surgery Market Attractiveness Analysis
    • 11.6.1. By Procedure
    • 11.6.2. By Disease Indication
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Minimally Invasive Surgery Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Asia Pacific Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017-2031
    • 12.2.1. Laparoscopic Surgery
      • 12.2.1.1. Orthopedic Surgery
      • 12.2.1.2. Thoracic Surgery
      • 12.2.1.3. Urology Surgery
      • 12.2.1.4. Gynecology Surgery
      • 12.2.1.5. Vascular Surgery
      • 12.2.1.6. General Surgery
      • 12.2.1.7. Cancer Surgery
      • 12.2.1.8. Breast Surgery
      • 12.2.1.9. Ear, Nose, and Throat Surgery
      • 12.2.1.10. Bariatric Surgery
    • 12.2.2. Robotic Surgery
      • 12.2.2.1. Orthopedic Surgery
      • 12.2.2.2. Cardiac Surgery
      • 12.2.2.3. Thoracic Surgery
      • 12.2.2.4. Urology Surgery
      • 12.2.2.5. Gynecology Surgery
      • 12.2.2.6. Vascular Surgery
      • 12.2.2.7. General Surgery
      • 12.2.2.8. Cancer Surgery
      • 12.2.2.9. Breast Surgery
      • 12.2.2.10. Ear, Nose, and Throat Surgery
      • 12.2.2.11. Bariatric Surgery
      • 12.2.2.12. Cosmetic/Plastic Surgery
      • 12.2.2.13. Neurosurgery
    • 12.2.3. Endoscopic Mucosal Resection
    • 12.2.4. Endoscopic Submucosal Dissection
    • 12.2.5. Transcatheter
      • 12.2.5.1. Cardiac Surgery
      • 12.2.5.2. Vascular Surgery
      • 12.2.5.3. Cancer Surgery
      • 12.2.5.4. Bariatric Surgery
  • 12.3. Asia Pacific Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017-2031
    • 12.3.1. Orthopedic Surgery
      • 12.3.1.1. Knee
      • 12.3.1.2. Spine
      • 12.3.1.3. Shoulder
      • 12.3.1.4. Others
    • 12.3.2. Cardiac Surgery
      • 12.3.2.1. Mitral Valve
      • 12.3.2.2. Aortic Valve
      • 12.3.2.3. Structural Heart Disease
      • 12.3.2.4. Tricuspid Valve
      • 12.3.2.5. Others
    • 12.3.3. General Surgery
      • 12.3.3.1. Gastrointestinal Surgery
      • 12.3.3.2. Hepatobiliary Pancreatic Surgery
    • 12.3.4. Urology Surgery
    • 12.3.5. Thoracic Surgery
    • 12.3.6. Gynecology Surgery
    • 12.3.7. Vascular Surgery
    • 12.3.8. Cancer Surgery
    • 12.3.9. Breast Surgery
    • 12.3.10. Ear, Nose, and Throat Surgery
    • 12.3.11. Bariatric Surgery
    • 12.3.12. Cosmetic/Plastic Surgery
    • 12.3.13. Neurosurgery
  • 12.4. Asia Pacific Minimally Invasive Surgery Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
      • 12.4.1.1. Orthopedic Surgery
      • 12.4.1.2. Cardiac Surgery
      • 12.4.1.3. Thoracic Surgery
      • 12.4.1.4. Urology Surgery
      • 12.4.1.5. Gynecology Surgery
      • 12.4.1.6. Vascular Surgery
      • 12.4.1.7. General Surgery
      • 12.4.1.8. Cancer Surgery
      • 12.4.1.9. Breast Surgery
      • 12.4.1.10. Ear, Nose, and Throat Surgery
      • 12.4.1.11. Bariatric Surgery
      • 12.4.1.12. Cosmetic/Plastic Surgery
      • 12.4.1.13. Neurosurgery
    • 12.4.2. Clinics
      • 12.4.2.1. Orthopedic Surgery
      • 12.4.2.2. Cardiac Surgery
      • 12.4.2.3. Thoracic Surgery
      • 12.4.2.4. Urology Surgery
      • 12.4.2.5. Gynecology Surgery
      • 12.4.2.6. Vascular Surgery
      • 12.4.2.7. General Surgery
      • 12.4.2.8. Cancer Surgery
      • 12.4.2.9. Breast Surgery
      • 12.4.2.10. Ear, Nose, and Throat Surgery
      • 12.4.2.11. Bariatric Surgery
      • 12.4.2.12. Cosmetic/Plastic Surgery
      • 12.4.2.13. Neurosurgery
    • 12.4.3. Ambulatory Surgical Centers
      • 12.4.3.1. Orthopedic Surgery
      • 12.4.3.2. Cardiac Surgery
      • 12.4.3.3. Thoracic Surgery
      • 12.4.3.4. Urology Surgery
      • 12.4.3.5. Gynecology Surgery
      • 12.4.3.6. Vascular Surgery
      • 12.4.3.7. General Surgery
      • 12.4.3.8. Cancer Surgery
      • 12.4.3.9. Breast Surgery
      • 12.4.3.10. Ear, Nose, and Throat Surgery
      • 12.4.3.11. Bariatric Surgery
      • 12.4.3.12. Cosmetic/Plastic Surgery
      • 12.4.3.13. Neurosurgery
    • 12.4.4. Others
      • 12.4.4.1. Orthopedic Surgery
      • 12.4.4.2. Cardiac Surgery
      • 12.4.4.3. Thoracic Surgery
      • 12.4.4.4. Urology Surgery
      • 12.4.4.5. Gynecology Surgery
      • 12.4.4.6. Vascular Surgery
      • 12.4.4.7. General Surgery
      • 12.4.4.8. Cancer Surgery
      • 12.4.4.9. Breast Surgery
      • 12.4.4.10. Ear, Nose, and Throat Surgery
      • 12.4.4.11. Bariatric Surgery
      • 12.4.4.12. Cosmetic/Plastic Surgery
      • 12.4.4.13. Neurosurgery
  • 12.5. Asia Pacific Minimally Invasive Surgery Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. Japan
    • 12.5.2. China
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Asia Pacific Minimally Invasive Surgery Market Attractiveness Analysis
    • 12.6.1. By Procedure
    • 12.6.2. By Disease Indication
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Minimally Invasive Surgery Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Latin America Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017-2031
    • 13.2.1. Laparoscopic Surgery
      • 13.2.1.1. Orthopedic Surgery
      • 13.2.1.2. Thoracic Surgery
      • 13.2.1.3. Urology Surgery
      • 13.2.1.4. Gynecology Surgery
      • 13.2.1.5. Vascular Surgery
      • 13.2.1.6. General Surgery
      • 13.2.1.7. Cancer Surgery
      • 13.2.1.8. Breast Surgery
      • 13.2.1.9. Ear, Nose, and Throat Surgery
      • 13.2.1.10. Bariatric Surgery
    • 13.2.2. Robotic Surgery
      • 13.2.2.1. Orthopedic Surgery
      • 13.2.2.2. Cardiac Surgery
      • 13.2.2.3. Thoracic Surgery
      • 13.2.2.4. Urology Surgery
      • 13.2.2.5. Gynecology Surgery
      • 13.2.2.6. Vascular Surgery
      • 13.2.2.7. General Surgery
      • 13.2.2.8. Cancer Surgery
      • 13.2.2.9. Breast Surgery
      • 13.2.2.10. Ear, Nose, and Throat Surgery
      • 13.2.2.11. Bariatric Surgery
      • 13.2.2.12. Cosmetic/Plastic Surgery
      • 13.2.2.13. Neurosurgery
    • 13.2.3. Endoscopic Mucosal Resection
    • 13.2.4. Endoscopic Submucosal Dissection
    • 13.2.5. Transcatheter
      • 13.2.5.1. Cardiac Surgery
      • 13.2.5.2. Vascular Surgery
      • 13.2.5.3. Cancer Surgery
      • 13.2.5.4. Bariatric Surgery
  • 13.3. Latin America Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017-2031
    • 13.3.1. Orthopedic Surgery
      • 13.3.1.1. Knee
      • 13.3.1.2. Spine
      • 13.3.1.3. Shoulder
      • 13.3.1.4. Others
    • 13.3.2. Cardiac Surgery
      • 13.3.2.1. Mitral Valve
      • 13.3.2.2. Aortic Valve
      • 13.3.2.3. Structural Heart Disease
      • 13.3.2.4. Tricuspid Valve
      • 13.3.2.5. Others
    • 13.3.3. General Surgery
      • 13.3.3.1. Gastrointestinal Surgery
      • 13.3.3.2. Hepatobiliary Pancreatic Surgery
    • 13.3.4. Urology Surgery
    • 13.3.5. Thoracic Surgery
    • 13.3.6. Gynecology Surgery
    • 13.3.7. Vascular Surgery
    • 13.3.8. Cancer Surgery
    • 13.3.9. Breast Surgery
    • 13.3.10. Ear, Nose, and Throat Surgery
    • 13.3.11. Bariatric Surgery
    • 13.3.12. Cosmetic/Plastic Surgery
    • 13.3.13. Neurosurgery
  • 13.4. Latin America Minimally Invasive Surgery Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
      • 13.4.1.1. Orthopedic Surgery
      • 13.4.1.2. Cardiac Surgery
      • 13.4.1.3. Thoracic Surgery
      • 13.4.1.4. Urology Surgery
      • 13.4.1.5. Gynecology Surgery
      • 13.4.1.6. Vascular Surgery
      • 13.4.1.7. General Surgery
      • 13.4.1.8. Cancer Surgery
      • 13.4.1.9. Breast Surgery
      • 13.4.1.10. Ear, Nose, and Throat Surgery
      • 13.4.1.11. Bariatric Surgery
      • 13.4.1.12. Cosmetic/Plastic Surgery
      • 13.4.1.13. Neurosurgery
    • 13.4.2. Clinics
      • 13.4.2.1. Orthopedic Surgery
      • 13.4.2.2. Cardiac Surgery
      • 13.4.2.3. Thoracic Surgery
      • 13.4.2.4. Urology Surgery
      • 13.4.2.5. Gynecology Surgery
      • 13.4.2.6. Vascular Surgery
      • 13.4.2.7. General Surgery
      • 13.4.2.8. Cancer Surgery
      • 13.4.2.9. Breast Surgery
      • 13.4.2.10. Ear, Nose, and Throat Surgery
      • 13.4.2.11. Bariatric Surgery
      • 13.4.2.12. Cosmetic/Plastic Surgery
      • 13.4.2.13. Neurosurgery
    • 13.4.3. Ambulatory Surgical Centers
      • 13.4.3.1. Orthopedic Surgery
      • 13.4.3.2. Cardiac Surgery
      • 13.4.3.3. Thoracic Surgery
      • 13.4.3.4. Urology Surgery
      • 13.4.3.5. Gynecology Surgery
      • 13.4.3.6. Vascular Surgery
      • 13.4.3.7. General Surgery
      • 13.4.3.8. Cancer Surgery
      • 13.4.3.9. Breast Surgery
      • 13.4.3.10. Ear, Nose, and Throat Surgery
      • 13.4.3.11. Bariatric Surgery
      • 13.4.3.12. Cosmetic/Plastic Surgery
      • 13.4.3.13. Neurosurgery
    • 13.4.4. Others
      • 13.4.4.1. Orthopedic Surgery
      • 13.4.4.2. Cardiac Surgery
      • 13.4.4.3. Thoracic Surgery
      • 13.4.4.4. Urology Surgery
      • 13.4.4.5. Gynecology Surgery
      • 13.4.4.6. Vascular Surgery
      • 13.4.4.7. General Surgery
      • 13.4.4.8. Cancer Surgery
      • 13.4.4.9. Breast Surgery
      • 13.4.4.10. Ear, Nose, and Throat Surgery
      • 13.4.4.11. Bariatric Surgery
      • 13.4.4.12. Cosmetic/Plastic Surgery
      • 13.4.4.13. Neurosurgery
  • 13.5. Latin America Minimally Invasive Surgery Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Latin America Minimally Invasive Surgery Market Attractiveness Analysis
    • 13.6.1. By Procedure
    • 13.6.2. By Disease Indication
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Minimally Invasive Surgery Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Middle East & Africa Minimally Invasive Surgery Market Value & Volume Forecast, by Procedure, 2017-2031
    • 14.2.1. Laparoscopic Surgery
      • 14.2.1.1. Orthopedic Surgery
      • 14.2.1.2. Thoracic Surgery
      • 14.2.1.3. Urology Surgery
      • 14.2.1.4. Gynecology Surgery
      • 14.2.1.5. Vascular Surgery
      • 14.2.1.6. General Surgery
      • 14.2.1.7. Cancer Surgery
      • 14.2.1.8. Breast Surgery
      • 14.2.1.9. Ear, Nose, and Throat Surgery
      • 14.2.1.10. Bariatric Surgery
    • 14.2.2. Robotic Surgery
      • 14.2.2.1. Orthopedic Surgery
      • 14.2.2.2. Cardiac Surgery
      • 14.2.2.3. Thoracic Surgery
      • 14.2.2.4. Urology Surgery
      • 14.2.2.5. Gynecology Surgery
      • 14.2.2.6. Vascular Surgery
      • 14.2.2.7. General Surgery
      • 14.2.2.8. Cancer Surgery
      • 14.2.2.9. Breast Surgery
      • 14.2.2.10. Ear, Nose, and Throat Surgery
      • 14.2.2.11. Bariatric Surgery
      • 14.2.2.12. Cosmetic/Plastic Surgery
      • 14.2.2.13. Neurosurgery
    • 14.2.3. Endoscopic Mucosal Resection
    • 14.2.4. Endoscopic Submucosal Dissection
    • 14.2.5. Transcatheter
      • 14.2.5.1. Cardiac Surgery
      • 14.2.5.2. Vascular Surgery
      • 14.2.5.3. Cancer Surgery
      • 14.2.5.4. Bariatric Surgery
  • 14.3. Middle East & Africa Minimally Invasive Surgery Market Value & Volume Forecast, by Disease Indication, 2017-2031
    • 14.3.1. Orthopedic Surgery
      • 14.3.1.1. Knee
      • 14.3.1.2. Spine
      • 14.3.1.3. Shoulder
      • 14.3.1.4. Others
    • 14.3.2. Cardiac Surgery
      • 14.3.2.1. Mitral Valve
      • 14.3.2.2. Aortic Valve
      • 14.3.2.3. Structural Heart Disease
      • 14.3.2.4. Tricuspid Valve
      • 14.3.2.5. Others
    • 14.3.3. General Surgery
      • 14.3.3.1. Gastrointestinal Surgery
      • 14.3.3.2. Hepatobiliary Pancreatic Surgery
    • 14.3.4. Urology Surgery
    • 14.3.5. Thoracic Surgery
    • 14.3.6. Gynecology Surgery
    • 14.3.7. Vascular Surgery
    • 14.3.8. Cancer Surgery
    • 14.3.9. Breast Surgery
    • 14.3.10. Ear, Nose, and Throat Surgery
    • 14.3.11. Bariatric Surgery
    • 14.3.12. Cosmetic/Plastic Surgery
    • 14.3.13. Neurosurgery
  • 14.4. Middle East & Africa Minimally Invasive Surgery Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
      • 14.4.1.1. Orthopedic Surgery
      • 14.4.1.2. Cardiac Surgery
      • 14.4.1.3. Thoracic Surgery
      • 14.4.1.4. Urology Surgery
      • 14.4.1.5. Gynecology Surgery
      • 14.4.1.6. Vascular Surgery
      • 14.4.1.7. General Surgery
      • 14.4.1.8. Cancer Surgery
      • 14.4.1.9. Breast Surgery
      • 14.4.1.10. Ear, Nose, and Throat Surgery
      • 14.4.1.11. Bariatric Surgery
      • 14.4.1.12. Cosmetic/Plastic Surgery
      • 14.4.1.13. Neurosurgery
    • 14.4.2. Clinics
      • 14.4.2.1. Orthopedic Surgery
      • 14.4.2.2. Cardiac Surgery
      • 14.4.2.3. Thoracic Surgery
      • 14.4.2.4. Urology Surgery
      • 14.4.2.5. Gynecology Surgery
      • 14.4.2.6. Vascular Surgery
      • 14.4.2.7. General Surgery
      • 14.4.2.8. Cancer Surgery
      • 14.4.2.9. Breast Surgery
      • 14.4.2.10. Ear, Nose, and Throat Surgery
      • 14.4.2.11. Bariatric Surgery
      • 14.4.2.12. Cosmetic/Plastic Surgery
      • 14.4.2.13. Neurosurgery
    • 14.4.3. Ambulatory Surgical Centers
      • 14.4.3.1. Orthopedic Surgery
      • 14.4.3.2. Cardiac Surgery
      • 14.4.3.3. Thoracic Surgery
      • 14.4.3.4. Urology Surgery
      • 14.4.3.5. Gynecology Surgery
      • 14.4.3.6. Vascular Surgery
      • 14.4.3.7. General Surgery
      • 14.4.3.8. Cancer Surgery
      • 14.4.3.9. Breast Surgery
      • 14.4.3.10. Ear, Nose, and Throat Surgery
      • 14.4.3.11. Bariatric Surgery
      • 14.4.3.12. Cosmetic/Plastic Surgery
      • 14.4.3.13. Neurosurgery
    • 14.4.4. Others
      • 14.4.4.1. Orthopedic Surgery
      • 14.4.4.2. Cardiac Surgery
      • 14.4.4.3. Thoracic Surgery
      • 14.4.4.4. Urology Surgery
      • 14.4.4.5. Gynecology Surgery
      • 14.4.4.6. Vascular Surgery
      • 14.4.4.7. General Surgery
      • 14.4.4.8. Cancer Surgery
      • 14.4.4.9. Breast Surgery
      • 14.4.4.10. Ear, Nose, and Throat Surgery
      • 14.4.4.11. Bariatric Surgery
      • 14.4.4.12. Cosmetic/Plastic Surgery
      • 14.4.4.13. Neurosurgery
  • 14.5. Middle East & Africa Minimally Invasive Surgery Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Middle East & Africa Minimally Invasive Surgery Market Attractiveness Analysis
    • 14.6.1. By Procedure
    • 14.6.2. By Disease Indication
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Company Profiles (Hospitals)
    • 15.2.1. Apollo Hospitals Enterprise Limited
      • 15.2.1.1. Services Portfolio
      • 15.2.1.2. SWOT Analysis
      • 15.2.1.3. Strategic Overview
    • 15.2.2. Huntington Hospital
      • 15.2.2.1. Services Portfolio
      • 15.2.2.2. SWOT Analysis
      • 15.2.2.3. Strategic Overview
    • 15.2.3. Johns Hopkins Hospital
      • 15.2.3.1. Services Portfolio
      • 15.2.3.2. SWOT Analysis
      • 15.2.3.3. Strategic Overview
    • 15.2.4. Massachusetts General Hospital
      • 15.2.4.1. Services Portfolio
      • 15.2.4.2. SWOT Analysis
      • 15.2.4.3. Strategic Overview
    • 15.2.5. Rutland Medical Center
      • 15.2.5.1. Services Portfolio
      • 15.2.5.2. SWOT Analysis
      • 15.2.5.3. Strategic Overview
    • 15.2.6. Saint Michael's Hospital
      • 15.2.6.1. Services Portfolio
      • 15.2.6.2. SWOT Analysis
      • 15.2.6.3. Strategic Overview
    • 15.2.7. Singapore General Hospital
      • 15.2.7.1. Services Portfolio
      • 15.2.7.2. SWOT Analysis
      • 15.2.7.3. Strategic Overview
    • 15.2.8. The Ottawa Hospital
      • 15.2.8.1. Services Portfolio
      • 15.2.8.2. SWOT Analysis
      • 15.2.8.3. Strategic Overview
    • 15.2.9. University of Pittsburgh Medical Center
      • 15.2.9.1. Services Portfolio
      • 15.2.9.2. SWOT Analysis
      • 15.2.9.3. Strategic Overview
    • 15.2.10. Washington Hospital Healthcare System
      • 15.2.10.1. Services Portfolio
      • 15.2.10.2. SWOT Analysis
      • 15.2.10.3. Strategic Overview
  • 15.3. Company Profiles (Instrument Providers)
    • 15.3.1. Abbott Laboratories
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. B. Braun Melsungen AG
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Becton, Dickinson and Company
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Boston Scientific Corporation
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. CONMED Corporation
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Johnson & Johnson Services, Inc.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Medtronic plc
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Smith & Nephew plc
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Stryker Corporation
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Zimmer Biomet
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제